Trade Agreements and Health in Developing Countries
Working Paper #196
Adverse effects of trade liberalization, and trade agreements on health are not inevitable. They are the result of how we have managed trade—to enhance proﬁts of the drug companies, not to enhance the health of those in the developing countries. The author proposes that we can reform our trade regimes and the way we ﬁnance and encourage research into drugs so as to improve health—and even lower costs.
About the Author
Initiative for Policy Dialogue (IPD)
Joseph E. Stiglitz is co-President of the Initiative for Policy Dialogue, and Chairman of the Committee on Global Thought at Columbia University. He is University Professor at Columbia, teaching in its Economics Department, its Business School, and its School of International and Public Affairs. He chaired the UN Commission of Experts on Reforms of the International Monetary and Financial System, created in the aftermath of the financial crisis by the President of the General Assembly. He is former Chief Economist and Senior Vice-President of the World Bank and Chairman of President Clinton’s Council of Economic Advisors. He was awarded the Nobel Memorial Prize in Economics in 2001.